Clinical Trials Browser

Phase 2 × OTHER_GOV × exemestane × Clear all

NCT07101159 2025-08-03

Dalpiciclib as Adjuvant Therapy for HR-positive/HER2-negative Early-stage Patients

Phase 2 Not yet recruiting

Breast Neoplasms

NCT03024580 2019-08-15

MEGA

Phase 2 Unknown

Breast Neoplasms